Evolus Inc banner

Evolus Inc
NASDAQ:EOLS

Watchlist Manager
Evolus Inc Logo
Evolus Inc
NASDAQ:EOLS
Watchlist
Price: 4.91 USD -8.91% Market Closed
Market Cap: $318.3m

Profitability Summary

Evolus Inc's profitability score is 37/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

37/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

37/100
Profitability
Score
37/100
Profitability
Score

Margins

Earnings Waterfall
Evolus Inc

Margins Comparison
Evolus Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Evolus Inc
NASDAQ:EOLS
318m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
923.3B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
582.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.6B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
223.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.1B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.8B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
152.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.7B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Evolus Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Evolus Inc
NASDAQ:EOLS
318m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
923.3B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
582.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.6B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
223.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.1B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
152.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.7B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Evolus Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett